Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 16 of 468 for:    ESCITALOPRAM AND Cholinergic

Escitalopram and Language Intervention for Subacute Aphasia (ELISA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03843463
Recruitment Status : Not yet recruiting
First Posted : February 18, 2019
Last Update Posted : March 6, 2019
Sponsor:
Collaborators:
University of South Carolina
Medical University of South Carolina
University of California, Irvine
Information provided by (Responsible Party):
Johns Hopkins University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : February 2024
Estimated Study Completion Date : February 2024
Publications:
Pan XL, Chen HF, Cheng X, Hu CC, Wang JW, Fu YM, Kong HM, Shao HJ. Effects of Paroxetine on Motor and Cognitive Function Recovery in Patients with Non-Depressed Ischemic Stroke: An Open Randomized Controlled Study. Brain Impairment. 2018 May:1-7.